We are live on ! Find out more
CUE icon

Cue Biopharma
CUE

80 hedge funds and large institutions have $39.7M invested in Cue Biopharma in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

632% more call options, than puts

Call options by funds: $769K | Put options by funds: $105K

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

25% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 20

24% more capital invested

Capital invested by funds: $32.1M → $39.7M (+$7.59M)

7% more funds holding

Funds holding: 75 → 80 (+5)

0.07% more ownership

Funds ownership: 1.04% → 1.11% (+0.07%)

Holders
80
Holders Change
+5
Holders Change %
+6.67%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
25
Reduced
20
Closed
6
Calls
$769K
Puts
$105K
Net Calls
+$664K
Net Calls Change
+$522K

Top Buyers

Rank Fund Capital Flow
1
BL
Bleichroeder LP
New York
+$2.38M
2
BlackRock
BlackRock
New York
+$500K
3
Morgan Stanley
Morgan Stanley
New York
+$488K
4
Bank of America
Bank of America
North Carolina
+$185K
5
Jane Street
Jane Street
New York
+$130K

Top Sellers

Rank Fund Capital Flow
1
SMH
Sanders Morris Harris
Texas
-$713K
2
SPC
Sigma Planning Corp
Michigan
-$324K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$259K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$140K
5
Wells Fargo
Wells Fargo
California
-$116K
Name Holding Trade Value Shares
Change 		Change in
Stake
SWM
51
SeaCrest Wealth Management
New York
$36.7K – – –
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
$36.7K -$140K -1,962 -81%
LPL Financial
53
LPL Financial
California
$34.1K +$5.65K +79 +22%
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$33K +$5.08K +71 +21%
New York State Common Retirement Fund
55
New York State Common Retirement Fund
New York
$31.4K -$143 -2 -0.5%
BPA
56
Beacon Pointe Advisors
California
$26.4K – – –
LCGC
57
Legacy Capital Group California
California
$26.4K +$23.8K +333 New
Fidelity Investments
58
Fidelity Investments
Massachusetts
$18K +$12K +168 +285%
GG
59
Gleason Group
Kentucky
$15.8K – – –
California State Teachers Retirement System (CalSTRS)
60
California State Teachers Retirement System (CalSTRS)
California
$15.6K -$4.08K -57 -22%
Citigroup
61
Citigroup
New York
$14.7K +$13.2K +185 +18,500%
AB
62
Amalgamated Bank
New York
$13K -$858 -12 -7%
TRCT
63
Tower Research Capital (TRC)
New York
$12.9K -$1.5K -21 -11%
Legal & General Group
64
Legal & General Group
United Kingdom
$11.1K – – –
NFSG
65
Newbridge Financial Services Group
Florida
$7.92K -$2.36K -33 -25%
AIP
66
Ameritas Investment Partners
Nebraska
$7.54K – – –
Comerica Bank
67
Comerica Bank
Texas
$3.89K +$3.5K +49 New
ACA
68
American Capital Advisory
Idaho
$2.64K +$2.36K +33 New
Northwestern Mutual Wealth Management
69
Northwestern Mutual Wealth Management
Wisconsin
$2.28K +$858 +12 +71%
BHWM
70
Beaird Harris Wealth Management
Texas
$2.1K – – –
KFS
71
Kelly Financial Services
Massachusetts
$1.32K – – –
HI
72
Harbour Investments
Wisconsin
$1.16K – – –
SS
73
Sunbelt Securities
Texas
$626 – – –
ASN
74
Advisory Services Network
Georgia
$528 +$500 +7 New
Russell Investments Group
75
Russell Investments Group
United Kingdom
$454 +$143 +2 +50%
1 2
3
4

CUE Hedge Fund Activity: Q4 2023 in Review

80 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cue Biopharma (CUE) for Q4 2023, worth a combined $39.7M — up 24% from $32.1M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CUE positions and 6 closed out — a net gain of 5 holders — while 25 added to existing stakes and 20 trimmed.

The largest buyer was Bleichroeder LP, adding an estimated $2.38M. The largest seller was Sanders Morris Harris, exiting entirely with an estimated $713K sold.

  • 80 institutional investors held Cue Biopharma (CUE) as of Q4 2023, up from 75 in Q3 2023.
  • Funds reported $39.7M of Cue Biopharma stock for Q4 2023, up 24% quarter-over-quarter.
  • 11 funds opened new Cue Biopharma positions in Q4 2023 and 6 closed out, a net change of +5 holders.
  • The largest Cue Biopharma buyer in Q4 2023 was Bleichroeder LP, an estimated $2.38M added.
  • The largest Cue Biopharma seller in Q4 2023 was Sanders Morris Harris, an estimated $713K sold.

Based on aggregated 13F filings for Q4 2023.